Profil

Nokin Marie-Julie

Biologie cellulaire et moléculaire

Département des sciences biomédicales et précliniques > GIGA Cancer - Tumours and development biology

See author's contact details
ORCID
0000-0003-0049-0970
Main Referenced Co-authors
Bellahcene, Akeila  (33)
Castronovo, Vincenzo  (32)
Peulen, Olivier  (29)
Durieux, Florence  (20)
Bellier, Justine  (17)
Main Referenced Keywords
Methylglyoxal (8); Cancer (4); Melanoma (4); Myoferlin (4); Pancreas (4);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (5)
GIGA‐R - Giga‐Research - ULiège [BE] (1)
Laboratoire de recherche sur les métastases (1)
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (1)
Main Referenced Disciplines
Oncology (64)
Biochemistry, biophysics & molecular biology (26)
Gastroenterology & hepatology (2)
Immunology & infectious disease (1)
Laboratory medicine & medical technology (1)

Publications (total 79)

The most downloaded
288 downloads
Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019 https://hdl.handle.net/2268/165469

The most cited

101 citations (Scopus®)

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375 https://hdl.handle.net/2268/207276

Donay, P., Nokin, M.-J., & Cataldo, D. (19 October 2023). Exposure to heated tobacco products alters the function of alveolar macrophages [Poster presentation]. EMDS.

Donay, P., Nokin, M.-J., & Cataldo, D. (01 June 2023). Exposure to heated tobacco products alters the function of lung macrophages [Paper presentation]. Basic Science Award Glaxo SmithKline.

Crake, R., Kiweler, N., Thiry, M., Peulen, O., Blomme, A., Meiser, J., Ambrogio, C., Santamaria, D., Cataldo, D., & Nokin, M.-J. (June 2023). Targeting metabolic adaptations in drug tolerant BRAFV600E mutant NSCLC [Poster presentation]. EACR 2023, Torino, Italy.

Dube, G., Tiamiou, A., Bizet, M., Boumahd, Y., Gasmi, I., Crake, R., Bellier, J., Nokin, M.-J., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (31 March 2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental and Clinical Cancer Research, 42 (1), 78. doi:10.1186/s13046-023-02637-w
Peer reviewed

Bendavid, G., Hubeau, C., Perin, F., Gillard, A., Nokin, M.-J., Carnet, O., Gerard, C., Noël, A., Lefèbvre, P., Rocks, N., & Cataldo, D. (05 January 2023). Role for the metalloproteinase ADAM28 in the control of airway inflammation, remodelling and responsiveness in asthma. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.1067779
Peer Reviewed verified by ORBi

Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., & Janji, B. (2023). Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer [Poster presentation]. GIGA day.

Donay, P., Nokin, M.-J., & Cataldo, D. (04 October 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. EDT Immunology Day.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (04 October 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. EDT Immunology Day, Sart-Tilman, Belgium.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (30 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. BACR Ghent.

Donay, P., Nokin, M.-J., & Cataldo, D. (09 September 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. Interuniversity phD day.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (09 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. EDT-BCMB, Namur, Belgium.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (06 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. GIGA Cancer Day 2022, Sart-Tilman, Belgium.

Donay, P., Nokin, M.-J., & Cataldo, D. (06 September 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. GIGA DAY 2022.

Donay, P., Nokin, M.-J., & Cataldo, D. (04 September 2022). Modifications of pulmonary macrophages function by heated tobacco products [Poster presentation]. ERS International Congress 2022, Barcelone, Spain.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (September 2022). Immunosuppressive effect of methylglyoxal stress in breast cancer [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Belgium.

Donay, P., Nokin, M.-J., & Cataldo, D. (29 June 2022). Metabolic modifications of pulmonary macrophages and their pro-tumoral phenotype after exposure to heated tobacco products [Poster presentation]. ISCaM 2022, Turin, Italy.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (22 June 2022). Diesel particles exposure favors lung cancer progression through induction of an inflammatory microenvironment [Poster presentation]. EACR Congress 2022, Seville, Spain.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (21 June 2022). Methylglyoxal reshapes breast tumor immune microenvironment [Poster presentation]. European association for cancer research congress 2022, Séville, Spain.

Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (25 May 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Paper presentation]. GSK Awards, Bruxelles, Belgium.

Ricciuti, B., Son, J., Okoro, J. J., Mira, A., Patrucco, E., Eum, Y., Wang, X., Paranal, R., Wang, H., Lin, M., Haikala, H. M., Li, J., Xu, Y., Alessi, J. V., Chloeu, C., Redig, A. J., Kohler, J., Dholakia, K. H., Chen, Y., ... Ambrogio, C. (2022). Comparative analysis and isoform-specific therapeutic vulnerabilities of KRAS mutations in non-small cell lung cancer. Clinical Cancer Research.
Peer Reviewed verified by ORBi

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (2022). Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer [Poster presentation]. PhD Day UNamur 2022, Belgium.

Kaminski, H., Marseres, G., Yared, N., Nokin, M.-J., Pitard, V., Zouine, A., Garrigue, I., Loizon, S., Capone, M., Gauthereau, X., Mamani-Matsuda, M., Coueron, Duran, R. V., Pinson, B., Pellegrin, I., Thiébaut, R., Couzi, L., Merville, P., & Dechanet-Merville, J. (January 2022). mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation. Journal of the American Society of Nephrology, 33 (1), 121-137. doi:10.1681/ASN.2020121753
Peer Reviewed verified by ORBi

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Nokin, M.-J., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (09 June 2021). Methylglyoxal Induces An Epigenetic Deregulation leading to the Silencing of Tumor-Suppressor Genes in Breast Cancer [Poster presentation]. EACR Congress, Innovative Cancer Science, Better Outcomes through Resarch.

Nguyen, T. L.* , Nokin, M.-J.* , Teres, S., Tome, M., Bodineau, C., Galmar, O., Pasquet, J.-M., Roussea, B., van Liempd, S., Falcon-Perez, J. M., Richard, E., Muzotte, E., Rezvani, H.-R., Priault, M., Bouchecareilh, M., Redonnet-Vernhet, I., Calvo, J., Uzan, B., Pflumio, F., ... Duran, R. V. (May 2021). Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Molecular Oncology, 15 (5), 1412-1431. doi:10.1002/1878-0261.12877
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Nokin, M.-J., Ambrogio, C., Nadal, E., & Santamaria, D. (May 2021). Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer. Trends in Cancer, 7 (5), 410-429. doi:10.1016/j.trecan.2020.11.005
Peer Reviewed verified by ORBi

Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966
Peer Reviewed verified by ORBi

Wissocq, T., Hubert, P., Caprasse, M., Nokin, M.-J., Noman, M. Z., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (07 February 2020). Methylglyoxal stress contributes to immunosuppression in breast cancer [Poster presentation]. Association Belge pour l'Etude du Cancer "A.B.E.C", Bruxelles, Belgium.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

Nokin, M.-J., Darbo, E., Travert, C., Drogat, B., Lacouture, A., San José, S., Cabrera, N., Turcq, B., Prouzet-Mauleon, V., Falcone, M., Villanueva, A., Wang, H., Herfs, M., Mosteiro, M., Jänne, P. A., Pujol, J.-L., Maraver, A., Barbacid, M., Nadal, E., ... Ambrogio, C. (2020). Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma. JCI Insight. doi:10.1172/jci.insight.137869
Peer Reviewed verified by ORBi

Nokin, M.-J. (17 October 2019). Targeting acquired vulnerabilities in Dabrafenib and Trametinib resistant BRAFV600E mutants LUAD [Paper presentation]. Chemistry meets Biology seminar, Bordeaux, France.

Bellier, J., Nokin, M.-J., Lardé, E., Karoyan, P., Peulen, O., Castronovo, V., & Bellahcene, A. (2019). Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Research and Clinical Practice. doi:10.1016/j.diabres.2019.01.002
Peer Reviewed verified by ORBi

Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7
Peer Reviewed verified by ORBi

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journe, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (26 November 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. Metabolism in cancer and Stromal Cells, Louvain, Belgium.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (28 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. 3rd symposium of ULB - Cancer Research Center (U-CRC), Bruxelles, Belgium.

Nokin, M.-J. (20 September 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Paper presentation]. Chemistry meets Biology seminar, Bordeaux, France.

Nguyen, T. L., Nokin, M.-J., Egorov, M., Tomé, M., Bodineau, C., Di Primo, C., Minder, L., Wdzieczak-Bakala, J., Garcia-Alvarez, M. C., Bignon, J., Thoison, O., Delpech, B., Surpateanu, G., Frapart, Y.-M., Peyrot, F., Abbas, K., Terès, S., Evrard, S., Khatib, A.-M., ... Collin, P. (15 September 2018). mTOR inhibition via displacement of phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells. Cancer Research, 78 (18), 5384-5397. doi:10.1158/0008-5472.CAN-18-0232
Peer Reviewed verified by ORBi

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (13 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. GIGA-Cancer Day 2018/EDT Cancerology, Liège, Belgium.

Nokin, M.-J. (02 July 2018). Dual role of Methylglyoxal, a glycolysis side-product, in cancer [Poster presentation]. 25th Biennial Congress Of The European Association For Cancer Research, Amsterdam, Netherlands.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Herfs, M., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (01 July 2018). Myoferlin controls mitochondrial structure and metabolism in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. EACR 25 50 Years, Amsterdam, Netherlands.

Bellier, J., Nokin, M.-J., Durieux, F., Journe, F., Ghanem, G., Castronovo, V., & Bellahcene, A. (30 June 2018). Methylglyoxal-induced Dicarbonyl Stress: Role in Melanoma Progression and Response to Therapy [Poster presentation]. Bellier, Amsterdam, Netherlands.

Nokin, M.-J. (24 May 2018). Methylglyoxal stress is associated with major ECM changes and the activation of MEK/ERK/SMAD1 signaling in highly metastatic breast cancer cells [Paper presentation]. Young Scientist Symposium, Bordeaux, France.

Nokin, M.-J. (22 May 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Poster presentation]. TOR de France meeting, Nice, France.

Nokin, M.-J. (22 May 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Paper presentation]. TOR de France meeting, Nice, France.

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z
Peer Reviewed verified by ORBi

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Koji, U., Spiegel A, Cochrane R, Hutton A, C., Castronovo, V., & Bellahcene, A. (27 January 2018). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Liège, Belgium.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège.

Bellahcene, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018). Methylglyoxal-derived stress: an emerging biological factor involved in the onset and progression of cancer. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2017.05.010
Peer Reviewed verified by ORBi

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress.

Nokin, M.-J. (20 October 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Paper presentation]. ISCaM annual meeting 2017, Bertinoro, Italy.

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Uchida, K., Spiegel A, D., Cochrane R, J., Hutton A, C., Castronovo, V., & Bellahcene, A. (19 October 2017). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Bertinoro, Italy.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium.

Nokin, M.-J. (24 February 2017). Methylglyoxal-induced carbonyl stress: perspectives of a new anti-GBM therapy [Paper presentation]. Télévie Glioblastoma Seminar.

Nokin, M.-J. (01 February 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. GIGA-Day 2017.

Nokin, M.-J. (28 January 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. BACR meeting 2017.

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213
Peer Reviewed verified by ORBi

Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7
Peer Reviewed verified by ORBi

Nokin, M.-J. (27 October 2016). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. ISCAM 2016.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375
Peer Reviewed verified by ORBi

Nokin, M.-J. (2016). Role of carbonyl stress in breast cancer progression and metastases development [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314907

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Nokin, M.-J. (22 April 2016). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. New frontiers in oxidative stress and redox regulation - FNRS contact group "Oxidative processes and antioxidants".

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Nokin, M.-J. (03 December 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Séminaire des chercheurs Télévie 2016.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom.

Durieux, F., Peixoto, P., Chiavarina, B., Nokin, M.-J., Karoyan, P., Castronovo, V., & Bellahcene, A. (28 September 2015). Characterization of new carbonyl scavenger molecules and their subsequent use for cancer therapy [Poster presentation]. Cancer and Metabolism Abcam 2015 Conference, Cambridge, United Kingdom.

Nokin, M.-J. (11 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Paper presentation]. EDT annual mini symposium 2015 "New advances in animal models in cancerology", Namur, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium.

Nokin, M.-J. (13 May 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Paper presentation]. GIGA-Cancer Day 2015, Liège, Belgium.

Nokin, M.-J. (11 February 2015). Accumulation of Methylglyoxal, a glycolysis by-product, modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. Séminaire des chercheurs Télévie 2015.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Lamour, V., Henry, A., Kroonen, J., Nokin, M.-J., von Marschall, Z., Fisher, L., Chau, T.-L., Chariot, A., Sanson, M., Delattre, J.-Y., Turtoi, A., Peulen, O., Rogister, B., Castronovo, V., & Bellahcene, A. (2015). Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer. doi:10.1002/ijc.29454
Peer Reviewed verified by ORBi

Nokin, M.-J. (30 September 2014). Downregulation of HSP90 by Methylgyoxal, a glycolysis by-product, is associated with YAP1 accumulation in breast cancer cells [Poster presentation]. EDT annual mini symposium 2014.

Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Nokin, M.-J. (19 May 2014). Glycation of YAP1 transcription factor by Methylglyoxal, a glycolysis by-product, induces its nuclear accumulation in human breast cancer cells [Poster presentation]. GIGA-Cancer Day 2014.

Nokin, M.-J. (05 December 2013). Triple negative human breast cancers accumulate significantly less Arg-pyrimidine moieties, methylglyoxal specific adducts, than other subtype lesions [Poster presentation]. Séminaire des chercheurs Télévie 2014.

Nokin, M.-J. (13 September 2013). Role of methylglyoxal, a side-product of glycolysis, in human breast cancer [Paper presentation]. EDT annual mini symposium 2013.

Nokin, M.-J. (17 May 2013). Role of Dentin Matrix Protein 1 (DMP1) in human breast cancer progression [Poster presentation]. GIGA-Cancer Day 2013.

Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019
Peer Reviewed verified by ORBi

Nokin, M.-J. (12 December 2012). Glucose-Regulated Protein 78 (GRP78): a potential cell surface receptor to Dentin Matrix Protein (DMP1) in human cancer cells? [Poster presentation]. Séminaire des chercheurs Télévie 2013.

Contact ORBi